Ugrás a tartalomra
Merck
Összes fotó(1)

Fontos dokumentumok

Összes dokumentáció megtekintése

S-008

Supelco

Sufentanil Citrate solution

100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

Bejelentkezésa Szervezeti és Szerződéses árazás megtekintéséhez
Összes fotó(1)

About This Item

Tapasztalati képlet (Hill-képlet):
C22H30N2O2S · C6H8O7
CAS-szám:
60561-17-3
Molekulatömeg:
578.67
EC-szám:
200-659-6
MDL-szám:
MFCD00072116
UNSPSC kód:
41116107
PubChem Substance ID:
329824410
NACRES:
NA.24

grade

certified reference material

Minőségi szint

300

Forma

liquid

Jellemzők

Snap-N-Spike®/Snap-N-Shoot®

kiszerelés

ampule of 1 mL

gyártó/kereskedő neve

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)

koncentráció

100 μg/mL in methanol (as free base)

technika/technikák

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

alkalmazás(ok)

forensics and toxicology

Formátum

single component solution

tárolási hőmérséklet

-10 to -25°C

SMILES string

OC(=O)CC(O)(CC(O)=O)C(O)=O.CCC(=O)N(c1ccccc1)C2(CCN(CCc3cccs3)CC2)COC

InChI

1S/C22H30N2O2S.C6H8O7/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-10,17H,3,11-16,18H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

Nemzetközi kémiai azonosító kulcs

OJCZPLDERGDQRJ-UHFFFAOYSA-N

Géninformáció

human ... OPRM1(4988)

Related Categories

Általános leírás

Sufentanil is a short acting synthetic opioid analgesic most commonly used for pain relief during medical operations. This certified solution standard is applicable to use in clinical toxicology, pain prescription monitoring, or forensic analysis by LC-MS/MS or GC/MS. Sufentanil is sold under the trade name Sufenta.

Jogi információk

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

kapcsolódó termék

Product No.
Leírás
Árazás

A-071

Alfentanil hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

P-071

Pain Management Multi-component Opiate Mixture-13 solution, 100 μg/mL each component (10 μg/mL Fentanyl), ampule of 1.0 mL, certified reference material, Cerilliant®

F-001

Fentanyl-D5 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

F-002

Fentanyl solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

F-013

Fentanyl solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

N-030

Norfentanyl-D5 oxalate solution, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-031

Norfentanyl oxalate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-055

Norfentanyl-D5 oxalate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

S-018

Sufentanil-D5 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

B-066

Butyryl fentanyl solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

C-162

Carfentanil Oxalate solution, (sold as 100 ug/mL in methanol as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

C-163

Carfentanil-D5 Oxalate solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

M-194

(±)-cis-3-Methylfentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-139

4-ANPP solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-049

p-Fluorofentanyl solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

I-038

Isobutyryl fentanyl hydrochloride solution, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

N-114

Norcarfentanil oxalate oxalate salt solution, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

V-048

Valeryl fentanyl hydrochloride solution, 100 μg/mL in methanol (as a free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-140

Acryl fentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

O-047

Ocfentanil solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-048

p-Fluorobutyryl fentanyl (PFBF) solution, 100 μg/mL in methanol (), certified reference material, ampule of 0.5 mL, Cerilliant®

H-130

(±)-β-Hydroxythiofentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

D-168

N-Desmethyl U-47700-D3 solution, 100 μg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

D-167

N-Desmethyl U-47700 solution, 1 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

F-050

4-Fluoro-isobutyryl fentanyl solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

A-157

4-ANPP-D5 solution, 100 μg/mL in methanol, certified reference material, ampule of 0.5 mL, Cerilliant®

F-054

o-Fluorofentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

M-200

Methoxyacetyl fentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

V-068

Valeryl fentanyl-D5 hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

C-177

Cyclopropyl fentanyl hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

F-053

Furanyl fentanyl-D5 hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

A-156

Acryl fentanyl-D5 hydrochloride solution, 100 μg/mL in methanol (as free base), certified reference material, ampule of 0.5 mL, Cerilliant®

Figyelmeztetés

Danger

Figyelmeztető mondatok

H225,H301 + H311 + H331,H370

Veszélyességi osztályok

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Célzott szervek

Eyes,Central nervous system

Tárolási osztály kódja

3 - Flammable liquids

WGK

WGK 2

Lobbanási pont (F)

49.5 °F - closed cup

Lobbanási pont (C)

9.7 °C - closed cup

Szabályozási jegyzékek

A szabályozási jegyzékek főként a vegyipari termékekre vonatkoznak. A nem vegyipari termékekről itt csak korlátozott információk adhatók meg. Ha nincs bejegyzés, az azt jelenti, hogy egyik összetevő sem szerepel a listán. A felhasználó kötelessége a termék biztonságos és jogszerű használatának biztosítása.

EU REACH Annex XVII (Restriction List)

CAS No.

Válasszon a legfrissebb verziók közül:

Analitikai tanúsítványok (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumentumok section.

Ha segítségre van szüksége, lépjen velünk kapcsolatba Vevőszolgálat

Már rendelkezik ezzel a termékkel?

Az Ön által nemrégiben megvásárolt termékekre vonatkozó dokumentumokat a Dokumentumtárban találja.

Dokumentumtár megtekintése

Q L Chen et al.
Acta anaesthesiologica Scandinavica, 57(2), 236-242 (2012-08-14)
Sufentanil is widely used in clinical anaesthesia because of its protective effects against ischaemia/reperfusion injury. Diabetes mellitus elevates the activity of glycogen synthase kinase-3β (GSK-3β), thereby increasing the permeability of mitochondrial transition pore. This study investigated the role of GSK-3β
Ramesh Rajan et al.
The European journal of neuroscience, 37(6), 924-941 (2013-01-03)
Many anaesthetics commonly used in auditory research severely depress cortical responses, particularly in the supragranular layers of the primary auditory cortex and in non-primary areas. This is particularly true when stimuli other than simple tones are presented. Although awake preparations
Shen Sun et al.
Journal of anesthesia, 27(1), 25-28 (2012-08-28)
We aimed to investigate the effects of pretreatment with a small dose of dexmedetomidine on the cough caused by sufentanil during anesthetic induction. Two hundred and forty patients undergoing elective gynecological surgery under general anesthesia were randomly allocated to 4
Harold S Minkowitz et al.
Regional anesthesia and pain medicine, 38(2), 131-139 (2012-12-29)
A sublingual sufentanil tablet is being developed as a potential alternative to intravenous (IV) opioids for the management of postoperative pain. The objective of these studies was to evaluate the pharmacokinetics, efficacy, and safety of sublingual sufentanil tablets for postoperative
Sébastien Grastilleur et al.
Biological chemistry, 394(3), 361-368 (2013-01-18)
Postoperative pain management is a clinical challenge that can be complicated by opioid-induced hyperalgesia (OIH). Kinin receptors could mediate both the acute and chronic phases of inflammation and pain. A few recent studies suggest that dynorphin A could maintain neuropathic
View All Related Papers

Tudóscsoportunk valamennyi kutatási területen rendelkezik tapasztalattal, beleértve az élettudományt, az anyagtudományt, a kémiai szintézist, a kromatográfiát, az analitikát és még sok más területet.

Lépjen kapcsolatba a szaktanácsadással